Eton Pharmaceuticals to Report First Quarter 2026 Financial Results on Thursday, May 14, 2026 Life Science Investing
SKYRIZI® Secures Listing on Ontario and Alberta Formularies in Ulcerative Colitis Pharmaceutical Investing
Bristol Myers Squibb Launches "Won't Lose" Media Campaign Ahead of FIFA World Cup 2026 Life Science Investing
Rezolute Announces Oral Presentation of Results From its Phase 3 sunRIZE Study of Ersodetug in Patients with Congenital Hyperinsulinism at the Pediatric Endocrine Society Annual Meeting Life Science Investing
Eton Pharmaceuticals relaunches HEMANGEOL® Oral Solution with Eton Cares and Exclusive Specialty Pharmacy Distribution Life Science Investing
Gilead Sciences to Present at Upcoming Second Quarter 2026 Investor Conferences Life Science Investing
AbbVie and adMare BioInnovations Announce RIME Therapeutics as AbbVie Biotech Innovators Award Recipient in Quebec Pharmaceutical Investing
CytomX Therapeutics to Report First Quarter 2026 Financial Results on May 7, 2026 Life Science Investing
